See Today's Golden Star Stocks 🔥 Free for 7 Days See Today's Golden Star Stocks 🔥 Free for 7 Days
NYSE:ATNM

Actinium Pharmaceuticals Stock News

etoro logo Buy ATNM
*Your capital is at risk
$0.84
-0.0001 (-0.0119%)
At Close: Jul 31, 2026
Forecast Earnings Financials Insider Trading Signals Historical Prices Predictions News Profile

The Daily Biotech Pulse: KemPharm, FDA Nod For Merck, Clovis Q3 Miss, 3 Stocks To Debut

 12:00am, Wednesday, 31'st Oct 2018

Has Actinium Pharmaceuticals (ATNM) Outpaced Other Medical Stocks This Year?

 12:00am, Monday, 22'nd Oct 2018

Investor Expectations to Drive Momentum within Motorola Solutions, Shire plc, Bitauto, GRIDSUM ...

 12:00am, Friday, 19'th Oct 2018

Actinium Reports Launch Of Iomab-ACT Program Offering Its Targeted, Chemo-Free, Lymphodepletion Technology As Universal Solution To CAR-T Product Developers

 12:00am, Monday, 01'st Oct 2018

Stocks Which Set New 52-Week High Yesterday, September 26th

 12:00am, Thursday, 27'th Sep 2018

Actinium Pharmaceuticals to host webinar introducing targeted lymphodepletion technology for CAR-T

 12:00am, Wednesday, 26'th Sep 2018

Actinium Pharmaceuticals (ATNM) Updates On Actimab-A MRD (Clinical trial for Minimal Residual Disease in Postremission AML Patients) - Slideshow

 12:00am, Wednesday, 11'th Jul 2018

3 Things In Biotech, June 29: The Highs And Lows (Very, Very Lows) Of Drug Development

 12:00am, Friday, 29'th Jun 2018

Actinium Announces New Clinical Trial to Study Effect of Actimab-A on Minimal Residual Disease in Postremission AML Patients

 12:00am, Thursday, 28'th Jun 2018

Actinium Pharmaceuticals Announces Dosing Of 38th Patient And 25 Percent Enrollment In Iomab-B Pivotal SIERRA Trial

 12:00am, Tuesday, 26'th Jun 2018
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE